The aim of the present study was to investigate the association between matrix metalloproteinase-9 (MMP-9) expression with BRAF V600E mutation and clinicopathological features, in Iranian papillary thyroid cancer (PTC) patients. | The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer